Clinical trial
Effectiveness and Biological Mechanism of Direct Ischemic Post-conditioning for Acute Stroke Patients Due to Large Vessel Occlusion: A Randomized Controlled Pilot Trial
NCT06545734 is registered in ClinicalTrials.gov with Tianjin Huanhu Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Biological Mechanism of Direct Ischemic Post-conditioning for Acute Stroke Patients Due to Large Vessel Occlusion: A Randomized Controlled Pilot Trial
- Lead sponsor
- Tianjin Huanhu Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 12, 2024
- Completion date
- August 15, 2025
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic conditioning, neuroprotection, stroke, acute